LGT CAPITAL PARTNERS LTD. - SYROS PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 3 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Links
Filings
EDGAR links
External links
Quarter-by-quarter ownership
LGT CAPITAL PARTNERS LTD. ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$529,000
-11.1%
550,000
+10.0%
0.02%
-5.9%
Q1 2022$595,000
-63.5%
500,0000.0%0.02%
-60.5%
Q4 2021$1,630,000
+740.2%
500,000
+1052.4%
0.04%
+616.7%
Q3 2021$194,000–43,388–0.01%–
 Download
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 881,450$5,677,0001.32%
IFP Advisors, Inc 50$1,0000.00%
Ten Capital Wealth Advisors, LLC 219$1,0000.00%
View complete list of SYROS PHARMACEUTICALS INC shareholders